Randomized controlled trialHumanClinical Trial, Phase II
Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder
The New England journal of medicine, 2021 Oct 14. Sikich L, Kolevzon A, King BH and 31 others.
Study type
Randomized controlled trial · Clinical Trial, Phase II
Subjects
Human participants (PubMed MeSH: Humans)
Journal
The New England journal of medicine
Published
2021 Oct 14
PubMed
Where PepCue cites this
This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.
Indexed under
MeSH terms assigned by the National Library of Medicine.
Administration, IntranasalAdolescentAutism Spectrum DisorderChildChild, PreschoolDouble-Blind MethodFemaleHumansLeast-Squares AnalysisMaleOxytocinSocial Behavior
Other papers on Oxytocin
Randomized controlled trial · 2020
Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial
Review · 2021Oxytocin, Neural Plasticity, and Social Behavior
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page